Intellectual property

Opportunities for licencing and commercialisation

Nottingham Trent University has a diverse portfolio of patents arising from academic research across the University. We have many years' experience in protecting our intellectual property and turning our innovation into commercial reality through the creation of spin-out companies, research and development with partner organisations and working with investors who are looking to realise the commercial potential of new technologies.

Please take a look at our portfolio of available technologies and get in touch if you would like to find out more.

Patents

Biomarker (SPAG5)
The invention relates to a method of determining the prognosis and suitable treatment of cancer in a subject by measuring the level of expression of SPAG5. In particular, it relates to a method where high expression of SPAG5 in tumour cells correlates with aggressive tumours especially breast and ovarian cancers.

Breast cancer assay (HAGE)
The invention relates to a method of identifying aggressive breast cancer tumours by considering the HAGE expression in the tumours.

Identification of patients for breast cancer therapy (T128)
The invention relates to methods of detecting or monitoring breast cancer in a subject, or identifying the prognosis of a subject with breast cancer comprising determining the level and/or position of the expression of a T128 family, and optionally one or both of ER and HER2 in a sample.

Inhibitor peptides of transglutaminase 2
Peptides which inhibit the transglutaminase family of enzymes, have been isolated from soya. The properties of these peptides could be useful in the alleviation of the symptoms of coeliac disease and fibrosis. They may also be useful as a treatment to prevent the formation of cataracts.

PAP vaccines for prostate cancer
This invention relates to peptide analogues from prostate acidic phosphatase (PAP) and their use as vaccines for prostate cancer. In particular, the analogue includes the change of alanine to leucine at position 115 of PAP which has been found to be particular advantageous.

Swarmonitor
The Swarmonitor project aims to develop a tool for diagnostic monitoring of honey bee colonies, by monitoring vibrations in the hive.

Surface Plasmon Resonance in Thin Films
The laser processing method invented at NTU and presented in this patent offers control and tunability of the Local Surface Plasmon Resonance presented by nanoparticles that are either on top of or embedded in thin film materials.

Spin-out companies

 

 

European Regional Development Fund (ERDF) logo